Diagnosis of resistance of the bacterium Helicobacter pylori to antibiotics
NewsThe bacterium Helicobacter pylori is classified as a group 1 carcinogen.
- It causes chronic active gastritis, and with prolonged inflammation can lead to the development of stomach cancer.
The prevalence of this infection remains at a very high level worldwide and in Russia ranges from 65 to 86%, depending on the region.
- Timely treatment is the prevention of stomach cancer.
Antibiotics are used in therapy, but their effectiveness depends on drug resistance.
- It is antibiotic resistance that experts consider to be the main reason for the ineffectiveness of the treatment.
Today, there is more and more data on the growth of antibiotic resistance in many countries of the world.
- Specialists of the Center for Personalized Medicine MCSC have developed a test system for molecular genetic diagnosis of H. pylori antibiotic resistance.
To date, the molecular genetic method is one of the most accurate.
The deadline is 2-4 days.
- This will help the doctor to choose the right therapy regimen in a timely manner.
The study is conducted under a contract for paid medical services.
Record by phone: 8 (495) 305-05-50.
